Ligand Pharmaceuticals Incorporated (LGND) quarterly cash flow statement — complete operating, investing & financing history
Ligand Pharmaceuticals Incorporated (LGND) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | 24.02M | 48.69M | 45.84M | 13.09M | 15.8M | -25.52M | 28.47M | 36.53M | 13.31M | 18.69M | 7.12M | 7.65M | -82K | 33.95M | 53.47M | 20.49M | 11.88M | 52.01M | 27.64M | 20.02M |
| Operating CF Margin % | 37.71% | 94.14% | 76.83% | 11.34% | 33.17% | -56.29% | 66.5% | 70.5% | 32.06% | 60.34% | 25.32% | 23.26% | -0.31% | 77.19% | 197.71% | 34.6% | 23.7% | 142.43% | 38.14% | 30.89% |
| Operating CF Growth % | 52.04% | 290.83% | 61.02% | -64.17% | 18.65% | -236.51% | 300.1% | 377.77% | 16336.59% | -44.94% | -86.69% | -62.68% | -100.69% | -34.73% | 93.44% | 2.32% | -41.71% | 383.64% | 5047.49% | 57.12% |
| Net Income | 48.51M | -13.35M | 44.78M | 117.27M | 4.85M | -42.45M | -31.09M | -7.17M | -51.91M | 86.14M | 18.19M | -10.27M | 2.29M | 43.61M | -14.53M | 404K | 12.6M | -12.93M | -3.19M | 13.72M |
| Depreciation & Amortization | 8.21M | 8.22M | 9.62M | 6.86M | 8.93M | 9.34M | 8.63M | 7.29M | 8.85M | 8.77M | 9.43M | 8.61M | 9.49M | 9.57M | 10.07M | 13.51M | 14.65M | 15.13M | 9.64M | 12.61M |
| Stock-Based Compensation | 13.65M | 10.6M | 14.27M | 14.75M | 0 | 0 | 7.52M | 26.23M | 11.06M | 7.33M | 0 | 6.88M | 7.21M | 0 | 0 | 12.6M | 0 | 0 | 0 | 0 |
| Deferred Taxes | 12.98M | 0 | -8.84M | 8.84M | -325K | -8.84M | -12.69M | -1.99M | -20.67M | 19.55M | 4.93M | 8.01M | -10M | 8.75M | 46.29M | -12.64M | 3.25M | -16.18M | -389K | 1.54M |
| Other Non-Cash Items | -52.34M | 37.34M | -23.28M | -124.02M | 8.51M | 21.61M | 44.5M | 12.8M | 73.59M | -111.34M | -9.45M | 15.25M | -3.6M | -35.88M | -14.93M | 1.62M | -3.93M | 17.2M | 35.59M | 5.96M |
| Working Capital Changes | -7M | 5.88M | 9.29M | -10.62M | -6.17M | -5.17M | 11.6M | -633K | -7.61M | 8.24M | -15.99M | -20.83M | -5.48M | 7.9M | 26.57M | 5.01M | -14.7M | 48.79M | -14.01M | -13.81M |
| Change in Receivables | -13.85M | 6.41M | -2.09M | -16.31M | -2.77M | -576K | -5.67M | 4.79M | -9.05M | 3.46M | 1.05M | -7.91M | 1.38M | 1.1M | 36.35M | -2.66M | -20.43M | 43.64M | -23.75M | -6.18M |
| Change in Inventory | 3M | -4.14M | 2.77M | 3.59M | -875K | -500K | 2.57M | 1.93M | 2.49M | 2.63M | 707K | -611K | -13M | 2.04M | 1.36M | 962K | 9.7M | 44K | 2.68M | -777K |
| Change in Payables | 3.25M | 2.71M | 7.34M | 1.09M | -407K | -2.15M | 11.29M | 2.23M | 0 | -1.38M | 2.76M | 0 | 0 | -435K | -2.94M | 3.95M | -1.65M | -2.71M | 6.45M | 705K |
| Cash from Investing | 321.12M | -94.35M | -18.1M | -353.44M | -10.67M | 4.89M | -38.62M | -46.51M | -54.76M | -3.77M | -10.28M | -19.5M | 7.56M | 10.55M | -7.28M | 19.18M | 37.85M | 113.88M | -35.71M | -18.22M |
| Capital Expenditures | -2.67M | -228K | -9K | -15K | -214K | -2.04M | -712K | 3.58M | -408K | -105K | -50.74M | -487K | -203K | -2.41M | -2.13M | -5.29M | -6.59M | -4.88M | -2.19M | -1.77M |
| CapEx % of Revenue | 4.19% | 0.44% | 0.02% | 0.01% | 0.45% | 4.49% | 1.66% | 6.91% | 0.98% | 0.34% | 180.58% | 1.48% | 0.77% | 5.49% | 7.88% | 8.93% | 13.14% | 13.35% | 3.03% | 2.73% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 80.19M | -96.19M | -75M | -998K | 0 | -25.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 463K | 7.41M | -8.42M | -14.76M | 2.03M | -4.47M | -66.34M | -43.92M | -1.97M | -501K | 69K | 136K | 83K | 130K | 12K | 47K | 33K | 0 | -861K | 0 |
| Cash from Financing | 546.43M | -14.13M | 8.33M | 409.64M | 15M | -4.68M | 20.39M | 55.08M | 9.49M | 12.22M | 6.26M | 3.27M | -67.76M | -775K | -5.3M | -40.83M | -59.44M | -170.42M | 4.16M | -385K |
| Debt Issued (Net) | 484.03M | -7K | 6.29M | 331.83M | -7K | -7K | -6K | -10K | -4K | -5K | -45K | -14K | -76.87M | -13K | 148K | -37.65M | -59.93M | -163.37M | 9.75M | -2.38M |
| Equity Issued (Net) | 62.7M | 7.65M | 9.3M | 78.13M | 8.24M | 4.22M | 3.11M | 21.39M | 0 | 15.3M | 6.53M | 0 | 0 | -762K | 7.42M | -96K | 604K | -5.51M | -8.26M | 1.9M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -60M | 0 | 0 | -15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -96K | 0 | 0 | -18.45M | 0 |
| Other Financing | -295K | -21.78M | -7.25M | -320K | 6.76M | -8.89M | 17.28M | 33.7M | 9.49M | -3.08M | -217K | 3.28M | 9.11M | 0 | -12.87M | -3.09M | -112K | -1.54M | 2.68M | 96K |
| Net Change in Cash | 891.61M | -59.83M | 35.55M | 71.71M | 19.68M | -24.32M | 8.69M | 45.48M | -31.95M | 27.14M | 3.68M | -8.59M | -60.28M | 43.72M | 40.89M | -1.16M | -9.71M | -4.53M | -3.91M | 1.42M |
| Free Cash Flow | 23.99M | 48.46M | 45.84M | 13.07M | 15.58M | -25.73M | 27.76M | 22.29M | 11.18M | 18.59M | 6.7M | 7.16M | -285K | 31.53M | 51.34M | 15.2M | 5.29M | 47.14M | 25.45M | 18.25M |
| FCF Margin % | 37.67% | 93.7% | 76.82% | 11.32% | 32.72% | -56.76% | 64.84% | 43.02% | 26.91% | 60% | 23.84% | 21.78% | -1.08% | 71.7% | 189.84% | 25.67% | 10.55% | 129.08% | 35.11% | 28.15% |
| FCF Growth % | 53.96% | 288.35% | 65.12% | -41.34% | 39.45% | -238.44% | 314.38% | 211.34% | 4021.05% | -41.06% | -86.95% | -52.9% | -105.39% | -33.1% | 101.76% | -16.73% | -66.05% | 541.31% | 748.99% | 70.46% |
| FCF per Share | 1.10 | 2.44 | 2.17 | 0.65 | 0.78 | -1.34 | 1.46 | 1.21 | 0.62 | 1.03 | 0.38 | 0.41 | -0.02 | 1.75 | 3.04 | 0.89 | 0.31 | 2.80 | 1.52 | 1.06 |
| FCF Conversion (FCF/Net Income) | 0.50x | -3.65x | 1.02x | 0.11x | 3.26x | 0.60x | -0.92x | -5.09x | -0.26x | 0.22x | 0.39x | -0.74x | -0.04x | 0.81x | -3.06x | 50.72x | -13.27x | -3.38x | -5.10x | 1.46x |
| Interest Paid | 2.27M | 0 | 0 | 98K | 0 | 0 | 0 | 0 | 53K | 0 | 0 | 0 | 288K | 0 | 0 | 101K | 0 | 0 | 0 | 0 |
| Taxes Paid | 2.54M | 0 | 0 | 621K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10K | 0 | 0 | 0 | 6.61M | 0 | 0 | 0 | 0 |